fda tirzepatide announcement Yesterday, the announced approval for Zepbound™ for weight management. Tirzepatide, the active ingredient in Zepbound™, is already approved under the trade name Mounjaro™ to be used along with diet and exercise Zepbound, Mounjaro shortages are resolved,

Thirty-six percent of covered workers in small firms are enrolled in a level-funded plan in 2024, similar to the percentage last year [Figure 10.6] and [Figure 10.8]

Why Tackling Weight Matters Maintaining a healthy weight is crucial, as excess weight can lead to serious health risks like type 2 diabetes, heart disease, high blood pressure, sleep apnea, joint pain, and certain cancers

GLP-1 drugs are generally covered for diabetes, but insurance companies and employers have been more reluctant to do the same for weight loss - in large part because they are so popular and require long-term use often enough that total spending threatens to spiral out of control

A boxed warning about thyroid tumors exists based on rodent studies, though human evidence remains limited

Naturopathic physicians are primary health care providers who are experts in the intersection of conventional practice and natural therapies